Affiliations: Department of Neurology, The Second Hospital of Lanzhou University, Lanzhou, China
Correspondence:
[*]
Correspondence to: Zhao-Ming Ge, Department of Neurology, the Second Hospital of Lanzhou University, 82
Cuiyingmen, Lanzhou 730000, China. Tel.: +86 13669380068; E-mail: gzm0701@yeah.net.
Abstract: The connection between diabetes and Alzheimer’s disease (AD) is not fully determined. Hyperphosphorylation of tau protein is mediated by binding and stabilization of truncated p25 with cyclin-dependent kinase-5 (CDK5) in AD. We recently showed that diabetes-associated hyperglycemia increased the CDK5 levels to promote development of AD. Here, we examined the underlying mechanisms. Hyperglycemia and glucose intolerance were induced in rats that had received a low dose of streptozotocin (STZ) and a high fat diet (HFD). Compared to the control rats that received no STZ and normal diet-fed, the STZ + HFD rats exhibited poorer performance in the behavioral test and showed hyperacetylation of H3K9 histone on CDK5 promoter, likely resulting from upregulation of a histone acetyltransferase, GCN5. Inhibition of acetylation of H3K9 histone by a specific GCN5 inhibitor, MB3, attenuated activation of CDK5, resulting in decreased tau phosphorylation in rat brain and improved performance of the rats in the behavior test. Thus, these data suggest that diabetes may promote future development of AD through hyperacetylation of H3K9 histone on CDK5 promoter.
Keywords: Alzheimer’s disease, cyclin-dependent kinase-5, diabetes, GCN5, H3K9
hyperacetylation, tau
